Stay updated on Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedPublications entries were updated. The Sharma et al. CheckMate 032 Lancet Oncology paper was added with its citation, and the prior erratum reference was replaced with a revised entry (version 3.5.4).SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a new revision label (v3.5.3) replacing the previous v3.5.2, indicating a software update to the page.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a publication citation for Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032) from Lancet Oncology with an Erratum. Replaced the older citation version (v3.5.0) with the updated entry (v3.5.2).SummaryDifference0.1%

- Check37 days agoChange DetectedPadua, Italy, 35128 was deleted and Padova, Italy, 35128 was added in the Locations section.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a publication citation for the CheckMate-032 study (J Clin Oncol, 2018). Deleted the erratum note for that publication (J Clin Oncol, 2019).SummaryDifference0.0%

- Check51 days agoChange DetectedNapoli, Italy, 80131 was changed to Naples, Italy, 80131 in the Locations section.SummaryDifference0.0%

Stay in the know with updates to Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Alone or Combined With Ipilimumab in Solid Tumors Clinical Trial page.